Total Liabilities for AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's latest reported total liabilities is $65.36B USD. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and net assets for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

AZN
Currently viewingRevenueSwitch metric
Latest period
$65.36B
YoY change
+3.5%
5Y CAGR
+5.0%
Peak year (2021)
$66.08B
Latest annual
$65.36B
Total Liabilities history chart for AstraZeneca (AZN) from 1990 to 2025
Total Liabilities history table for AstraZeneca (AZN) from 1990 to 2025
| Fiscal year | Period ended | Reported | Total Liabilities | YoY |
|---|---|---|---|---|
| 2025 | $65.36B | +3.5% | ||
| 2024 | $63.16B | +2.0% | ||
| 2023 | $61.95B | +4.3% | ||
| 2022 | $59.42B | -10.1% | ||
| 2021 | $66.08B | +29.3% | ||
| 2020 | $51.09B | +9.2% | ||
| 2019 | $46.78B | +0.4% | ||
| 2018 | $46.61B | -0.2% | ||
| 2017 | $46.71B | +1.9% | ||
| 2016 | $45.86B | +10.2% | ||
| 2015 | $41.62B | +6.8% | ||
| 2014 | $38.95B | +19.3% | ||
| 2013 | $32.65B | +10.4% | ||
| 2012 | $29.58B | +0.8% | ||
| 2011 | $29.36B | -10.3% | ||
| 2010 | $32.72B | -4.1% | ||
| 2009 | $34.10B | +10.4% | ||
| 2008 | $30.89B | -6.5% | ||
| 2007 | $33.04B | +127.6% | ||
| 2006 | $14.52B | +30.2% | ||
| 2005 | $11.15B | -0.1% | ||
| 2004 | $11.15B | +8.1% | ||
| 2003 | $10.32B | -0.3% | ||
| 2002 | $10.35B | -18.4% | ||
| 2001 | $12.68B | +42.5% | ||
| 2000 | $8.90B | -6.0% | ||
| 1999 | $9.47B | +99.2% | ||
| 1998 | $4.75B | +2.0% | ||
| 1997 | $4.66B | -5.0% | ||
| 1996 | $4.90B | +1.4% | ||
| 1995 | $4.83B | +5.2% | ||
| 1994 | $4.59B | -9.9% | ||
| 1993 | $5.10B | -15.3% | ||
| 1992 | $6.02B | +10.5% | ||
| 1991 | $5.45B | +0.5% | ||
| 1990 | $5.42B | — |
Total Liabilities values are taken from AstraZeneca's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, AstraZeneca (AZN) reported total liabilities of $65.36B – edged up 3.5% year-over-year.
AstraZeneca total liabilities has recorded the values shown across consecutive periods, with a +5.0% compound annual growth rate over 2020–2025 (5 years).
$66.08B stands as the all-time-high annual total liabilities, posted in 2021, against a low of $4.59B during 1994.
AstraZeneca (AZN) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $101.80B.
AstraZeneca Total Liabilities by Year
AstraZeneca Total Liabilities 2025: $65.36B
AstraZeneca total liabilities in 2025 was $65.36B, edged up 3.5% from 2024.
AstraZeneca Total Liabilities 2024: $63.16B
AstraZeneca total liabilities in 2024 was $63.16B, edged up 2.0% from 2023.
AstraZeneca Total Liabilities 2023: $61.95B
AstraZeneca total liabilities in 2023 was $61.95B, edged up 4.3% from 2022.
AstraZeneca Total Liabilities 2022: $59.42B
AstraZeneca total liabilities in 2022 was $59.42B, declined 10.1% below 2021.
AstraZeneca Total Liabilities 2021: $66.08B
AstraZeneca total liabilities in 2021 was $66.08B.
See more financial history for AstraZeneca (AZN).
Sector peers — Total Liabilities
Companies in the same sector as AstraZeneca, ranked by their latest total liabilities.
| Company | Total Liabilities | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $348.86B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $207.88B | Healthcare |
| AbbVie Inc. (ABBV) | $137.19B | Healthcare |
| Johnson & Johnson (JNJ) | $117.67B | Healthcare |
| Eli Lilly and Company (LLY) | $85.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $84.20B | Healthcare |
| Amgen Inc. (AMGN) | $81.93B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $56.81B | Healthcare |
Frequently asked questions
What is AstraZeneca's total liabilities?
- Latest reported total liabilities for AstraZeneca (AZN) is $65.36B (period ending December 31, 2025).
How has AstraZeneca total liabilities changed year-over-year?
- AstraZeneca (AZN) total liabilities changed +3.5% year-over-year on the latest annual filing.
What is the long-term growth rate of AstraZeneca total liabilities?
- AstraZeneca (AZN) total liabilities compound annual growth rate is +5.0% over the most recent 5 years available.
When did AstraZeneca total liabilities hit its highest annual value?
- AstraZeneca total liabilities reached its highest annual value of $66.08B in 2021.
What was AstraZeneca total liabilities in 2024?
- AstraZeneca (AZN) total liabilities in 2024 was $63.16B.
What was AstraZeneca total liabilities in 2025?
- AstraZeneca (AZN) total liabilities in 2025 was $65.36B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
AZN Overview
Company profile, financial tools, and key metrics
AZN Revenue Counter
Earns $1,863 every second. See per minute, hour, and day.
AZN Earnings Counter
Earns $324.23 per second net profit. See per minute, hour, and day.
AZN Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
AZN What If Invested
What if you had invested $1,000? See historical returns from any date.
AZN How It Makes Money
Discover visual breakdown of $58.74B in revenue — where it comes from and where it goes.
AZN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AZN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AZN Daily Price Character
Steady · 49.4% historical win rate (green days). Streaks & record days.
AZN Buybacks
0.16% TTM buyback yield. Shareholder yield & SBC comparison.
AZN Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
AZN Dividend Profile
Yield: 1.73%. Safety: 6/8. See full history.
AZN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AZN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.